Topic: Biology
Scientists have created a powerful light-based sensor that can detect tiny amounts of cancer biomarkers in blood. This innovation could lead to earlier diagnosis and better treatment options.
This new technology uses DNA, quantum dots, and CRISPR gene editing to detect faint biomarker signals. The sensor is designed to work with extremely low concentrations of biomarkers, making it more accurate than current methods.
The researchers tested the device using human serum from lung cancer patients and found that it worked exceptionally well. This breakthrough could lead to simpler blood screenings for lung cancer before a tumor appears on a CT scan.
The team's approach eliminates the need for chemical amplification, which adds time, complexity, and expense. Instead, they use second harmonic generation (SHG) to convert incoming light into light with half the wavelength. This process takes place on the surface of a two-dimensional semiconductor called molybdenum disulfide (MoS₂).
The sensor relies on DNA tetrahedrons, which are small pyramid-shaped nanostructures formed entirely from DNA. These structures hold quantum dots at carefully controlled distances from the MoS₂ surface. The quantum dots intensify the local optical field and boost the SHG signal.
CRISPR-Cas gene editing technology is then incorporated to recognize specific biomarkers. When the Cas12a protein detects its target, it cuts the DNA strands that anchor the quantum dots. This action triggers a measurable drop in the SHG signal.
Why It Matters
This breakthrough could lead to earlier diagnosis and better treatment options for cancer patients in India. It also highlights the potential of combining biology, nanomaterials, and optics to develop new diagnostic platforms.
Key Facts
- Scientists have designed a powerful light-based sensor that can detect tiny amounts of cancer biomarkers in blood.
- The sensor uses DNA, quantum dots, and CRISPR gene editing to detect faint biomarker signals.
- The device was tested using human serum from lung cancer patients and found to work exceptionally well.
Key Terms
- Second harmonic generation (SHG)
- A process that converts incoming light into light with half the wavelength
Implications
This breakthrough could lead to earlier diagnosis and better treatment options for cancer patients in India. It also highlights the potential of combining biology, nanomaterials, and optics to develop new diagnostic platforms.
Source: https://www.sciencedaily.com/releases/2026/02/260216044002.htm
Journal Reference:
- Bowen Du, Xilin Tian, Siyi Han, Yi Liu, Zhi Chen, Yong Liu, Linjun Li, Zheng Xie, Lingfeng Gao, Ke Jiang, Qiao Jiang, Shi Chen, Han Zhang. Sub-attomolar-level biosensing of cancer biomarkers using SHG modulation in DNA-programmable quantum dots/MoS2disordered metasurfaces. Optica, 2026; 13 (2): 319 DOI: 10.1364/OPTICA.577416
Leave a Comment